http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0254327-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b4beef0c137d9094e6918ee382be22f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-84 |
filingDate | 1987-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2072a896a91b5646923e189dace71f2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_336040cdef776c597d0522a461fdd31f |
publicationDate | 1988-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0254327-A2 |
titleOfInvention | N-N-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl) oxyalkylamides and related compounds |
abstract | Pharmaceutical compositions comprising, or compositions consisting essentially of, compounds according to the formulan or an optical isomer thereof wherein nZ is oxygen or NR²; nn is an integer of 1 to 6; nR¹ and R² are independently hydrogen; alkyl of 1 to 12 carbon atoms; cycloalkyl of 3 to 12 carbon atoms; hydroxalkyl of 1 to 6 carbon atoms; cycloalkyl lower alkyl of 4 to 12 carbon atoms wherein the cycloalkyl ring is optionally substituted with a lower alkyl, lower alkoxy, -OH, -OCOR³, halo, -N(R³)₂, -NHCOR³, -COOH, or -COOR³ group wherein R³ is lower alkyl; and phenyl or phenyl lower alkyl wherein phenyl is optionally substituted with at least one lower alkyl, halo or lower alkoxy group or an -N(R³)₂, -NHCOR³, -COOH, or -COOR³ group wherein R³ is lower alkyl; or R¹ and R² are combined with the N to which they are attached to form a cyclic secondary amine radical having from 5 to 8 atoms, where, in addition to the N atom, the atoms in the radical comprise carbon atoms and can include one oxygen or sulfur atom, or one optionally lower alkyl substituted nitrogen atom; nHX is optionally present and when present represents the acid portion of a pharmaceutically acceptable acid additional salt; n A is NR⁴R⁵ wherein R⁴ and R⁵ are independently selected from the group consisting of: hydrogen; alkyl of 1 to 6 carbon atoms; hydroxyalkyl of 2 to 6 carbon atoms; cycloalkyl of 3 to 8 carbon atoms or cycloalkyl lower alkyl of 4 to 12 carbon atoms wherein the cycloalkyl ring is optionally substituted with a lower alkyl, lower alkoxy, -OH, -OCOR³, halo, -N(R³)₂, -NHCOR³, -COOH, or -COOR³ group wherein R³ is lower alkyl; and phenyl or phenyl lower alkyl wherein phenyl is optionally substituted with at least one lower alkyl, halo or lower alkoxy group or an -N(R³)₂, -NHCOR³, -COOH, or -COOR³ group wherein R³ is lower alkyl; or wherein R⁴ and R⁵ are combined to form a compound selected from the group consisting of: morpholinyl, piperidinyl, perhexylenyl, N-loweralkylpiperazinyl, pyrrolidinyl, tetrahydroquinolinyl, tetrahydroisoquinolinyl, (±)-decahydroquinolinyl and indolinyl. The invention is also directed to certain compounds of the above class. The compounds of Formula I are cyclic AMP phosphodiesterase inhibitors useful as antithrombotic and inotropic agents and the like in mammals. |
priorityDate | 1986-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1132.